Navigation Links
Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights
Date:7/30/2009

accordance with SFAS No. 123(R) or approximately $0.06 and $0.05 effect on basic and diluted net loss per common share for the six months ended June 30, 2009 and 2008, respectively. Research and development expense and general and administrative expense includes $944 and $802, respectively, of non-cash operating expenses determined in accordance with SFAS No. 123(R) for the six months ended June 30, 2009.

                         Anadys Pharmaceuticals, Inc.
                    Condensed Consolidated Balance Sheets
                                (In thousands)

                                                      June 30,    December 31,
                                                        2009          2008
                                                     (Unaudited)    (Audited)
    Assets

    Cash, cash equivalents and securities
     available-for-sale                                $30,620      $27,936
    Other current assets                                 2,576        2,202
    Noncurrent assets                                      956        1,536
                                                       -------      -------
        Total assets                                   $34,152      $31,674
                                                       =======      =======

    Liabilities and Stockholders' Equity

    Current liabilities                                 $8,733       $5,813
    Other long-term liabilities                             32           36
    Stockholders' equity                                25,387       25,825
                                                       -------      -------
        Total liabilities and stockholders' equity     $34,152      $31,674
                                                       =======      =======

Pegasys(R) and Copegus(R) are registe
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Anadys Pharmaceuticals to Report Second Quarter 2009 Financial Results
2. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
3. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
4. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
5. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
6. Anadys Pharmaceuticals to Present at the Piper Jaffray Health Care Conference
7. Anadys Pharmaceuticals to Present at the Needham Focus on Infectious Disease Conference
8. Anadys Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
9. Anadys Pharmaceuticals Commences Dosing ANA773 in Hepatitis C Patients
10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
11. Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage ... Exchange: PBT.U), and Biohaven Pharmaceutical Holding Company Limited ... a Phase I study of BHV-0223, a glutamate ... (IND) regarding BHV-0223 and recently obtained clearance from ... proceed with human testing. Portage holds 54% equity ...
(Date:8/27/2015)... Aug. 27, 2015 HUYA Bioscience International (HUYA) today ... the Japan Society of HTLV-1, held this week at ... purpose of the Society is to promote research on ... of medical technology and research related to these fields ... "HUYA is proud to support this prestigious conference," ...
(Date:8/27/2015)... 27, 2015 In response to recent ... and The US Postal Service to no longer ... ,select agents, by the CDC, Marken reaffirmed today ... sensitive shipments. Marken uses its flexible ... and certified personnel to ensure the safe and ...
(Date:8/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... testing solutions for the detection of foodborne pathogens, today ... the Sidoti & Company Emerging Growth Conference on September ... at the New York Marriott Marquis. ... through the investor relations section of Roka Bioscience,s website ...
Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Marken Ensures Safe Transportation Of Select Agents And Toxins 2
... Nov. 15 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President,and ... ONCY), will present a,corporate overview of the company ... The event is being held at the National ... About Oncolytics Biotech Inc. Oncolytics is a ...
... Pitch for,U-Md. Bioscience Day, COLLEGE PARK, Md., Nov. ... new technology enabling him to develop an,infinite variety of ... of,venture capitalists and the title of "Best Inventor Pitch" ... the university,s Office of Technology Commercialization,the College of Chemical ...
... Stock Exchange Symbol: MS, EDMONTON, Nov. 14 ... developer in the treatment of multiple sclerosis (MS), ... quarter, ended,September 30, 2007. "During the quarter, ... our lead drug, MBP8298, for the treatment of ...
Cached Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society 2Pure Plastics Pitch Proves Perfect 2Pure Plastics Pitch Proves Perfect 3BioMS Medical announces third quarter 2007 results 2BioMS Medical announces third quarter 2007 results 3BioMS Medical announces third quarter 2007 results 4
(Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... think may be a basic recipe for capturing and ... from essentially any mammal, including cows, pigs and even ... issue of the journal Cell , a Cell ... work in mice earlier this year, which includes inhibitory ...
... of Rochester have shown that the human brainonce thought ... to allow us to make the best decisions possible ... published in today,s issue of the journal Neuron ... 2002 Nobel Prize for their 1979 research that argued ...
... Research Institute scientists, along with colleagues from the University ... to deliver one of those research raritiesan unmitigated success. ... remarkable accuracy, predicts how bacterial proteins fold and interact. ... in this week,s Early Edition of the Proceedings ...
Cached Biology News:Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests 2Recipe for capturing authentic embryonic stem cells may apply to any mammal, study suggests 3Our unconscious brain makes the best decisions possible 2Our unconscious brain makes the best decisions possible 3New technique is quantum leap forward in understanding proteins 2New technique is quantum leap forward in understanding proteins 3New technique is quantum leap forward in understanding proteins 4
Component in MasterPure™ Purification Kits...
...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Human Cell Line Slides...
Biology Products: